Human medicines European public assessment report (EPAR): Alimta, pemetrexed, Date of authorisation: 20/09/2004, ...
For the treatment of malignant pleural mesothelioma, Alimta in combination with cisplatin has been compared with cisplatin alone in one main study in 456 patients who had not received chemotherapy for their disease before. For the treatment of locally …